Race Oncology Ltd Faces Increased Revenue and Losses

Race Oncology Ltd. (AU:RAC) has released an update.

Race Oncology Ltd. reported a 41% increase in revenue to $832,577 for the fiscal year ending June 30, 2024, but also a 39% deeper net loss of $13.8 million compared to the previous year. Despite the increased revenue, operational losses widened, and the company ended the year with a lower cash balance of $17.2 million and net assets of $18.3 million, indicating a challenging financial period.

For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.